American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon CancerAl B. Benson, Daniel G. Haller, Pamela K. McAllister et al.|Journal of Clinical Oncology|2004Cited by 1.5k
Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood FlowJames Stevenson, Peter J. O’Dwyer, Mark Rosen et al.|Journal of Clinical Oncology|2003Cited by 293
Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinomaWeijing Sun, Kim M. Olthoff, Davendra Sohal et al.|Cancer|2011Cited by 97
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009Eric Van Cutsem, Josep Tabernero, M. Dicato et al.|Annals of Oncology|2010Cited by 80